CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 877696-877816 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Additionally, frequency of EBVreactive CD8-cells in the MS group was higher than in controls (mean 0.52% against 0.12%).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T34803","span":{"begin":0,"end":120},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T34803","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T138","span":{"begin":0,"end":120},"obj":"Sentence"}],"attributes":[{"subj":"T138","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5393","span":{"begin":56,"end":58},"obj":"Disease"},{"id":"T79404","span":{"begin":56,"end":58},"obj":"Disease"}],"attributes":[{"id":"A5393","pred":"mondo_id","subj":"T5393","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A10015","pred":"mondo_id","subj":"T79404","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"subj":"T5393","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T79404","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecc493","default":true},{"id":"CORD-19_Custom_license_subset","color":"#aa93ec"},{"id":"CORD-19-PD-MONDO","color":"#95ec93"}]}]}}